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a b s t r a c t
Lipid peroxidation products have been known to induce cellular adaptive responses and enhance
tolerance against subsequent oxidative stress through up-regulation of antioxidant compounds and
enzymes. 24S-hydroxycholesterol (24SOHC) which is endogenously produced oxysterol in the brain plays
an important role in maintaining brain cholesterol homeostasis. In this study, we evaluated adaptive
responses induced by brain-speciﬁc oxysterol 24SOHC in human neuroblastoma SH-SY5Y cells. Cells
treated with 24SOHC at sub-lethal concentrations showed signiﬁcant reduction in cell death induced by
subsequent treatment with 7-ketocholesterol (7KC) in both undifferentiated and retinoic acid-
differentiated SH-SY5Y cells. These adaptive responses were also induced by other oxysterols such as
25-hydroxycholesterol and 27-hydroxycholesterol which are known to be ligands of liver X receptor
(LXR). Co-treatment of 24SOHC with 9-cis retinoic acid, a retinoid X receptor ligand, enhanced the
adaptive responses. Knockdown of LXRβ by siRNA diminished the adaptive responses induced by
24SOHC almost completely. The treatment with 24SOHC induced the expression of LXR target genes,
such as ATP-binding cassette transporter A1 (ABCA1) and G1 (ABCG1). The 24SOHC-induced adaptive
responses were signiﬁcantly attenuated by siRNA for ABCG1 but not by siRNA for ABCA1. Taken together,
these results strongly suggest that 24SOHC at sub-lethal concentrations induces adaptive responses via
transcriptional activation of LXR signaling pathway, thereby protecting neuronal cells from subsequent
7KC-induced cytotoxicity.
& 2013 The Authors. Published by Elsevier B.V. All rights reserved.
Introduction
The oxidative modiﬁcation of biomolecules (proteins, lipids,
nucleic acids) under oxidative stress has been implicated in a
variety of pathological events such as atherosclerosis, cancer and
neurodegenerative diseases [1–3]. These oxidation products have
been suggested to act as biomarkers providing evidence of
elevated oxidative stress in our bodies [4–6]. Some of these
products are so active that they enhance further oxidative stress,
resulting in development of diseases and aging. It has also been
known that many oxidation products, especially lipid peroxidation
products possess a variety of physiological functions [7]. Such lipid
peroxidation products include oxysterols, which are oxidized
forms of cholesterol [8]. Oxysterols have diverse functions not
possessed by cholesterol. While oxysterols play important roles in
signal transduction and lipid homeostasis [9], their pro-oxidative
and pro-inﬂammatory activities resulting in cell death have been
implicated in the pathogenesis of a variety of diseases [10].
Enhanced oxidative stress has been suggested to play an impor-
tant role in the pathogenesis of neurodegenerative diseases such as
Alzheimer's disease (AD) and Parkinson's disease [11,12]. Oxidation
of cholesterol proceeds enzymatically and non-enzymatically in the
brain [9,13]. When cholesterol is attacked by reactive oxygen species
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at the 7-position, oxysterols such as 7-ketocholesterol (7KC) and
7β-hydroxycholesterol are generated. Since the highly cytotoxic
potential of 7KC has been shown in neuronal cells [14–16], 7KC is
suspected to be involved in the pathogenesis of neurodegenerative
diseases.
Cholesterol is also oxidized enzymatically to produce oxysterols
such as 24S-hydroxycholesterol (24SOHC), 25-hydroxycholesterol
(25OHC), and 27-hydroxycholesterol (27OHC). Of these, 24SOHC is
the most abundant oxysterol in the brain. It has been reported
that free 24SOHC is present at high concentrations (about 30 μM)
in human brain homogenate [17]. Cholesterol 24-hydroxylase
(CYP46A1), which is predominantly expressed in the brain, cata-
lyzes the conversion of cholesterol to 24SOHC [13,18]. Since
cholesterol does not penetrate the blood–brain barrier, excess
amounts of cholesterol in the brain are converted to 24SOHC,
which readily crosses the blood–brain barrier to be eliminated [19].
24SOHC is also known to act as an endogenous ligand of liver X
receptor (LXR), a transcription factor regulating cholesterol efﬂux.
Therefore, CYP46A1 and 24SOHC play pivotal roles in brain choles-
terol homeostasis. While 24SOHC is an important physiological
molecule, several lines of evidence suggest that 24SOHC is linked to
the development of AD [20–22]. Higher concentrations of 24SOHC
were detected in plasma and cerebrospinal ﬂuid of patients with AD
and mild cognitive impairment compared to healthy donors.
Furthermore, neurotoxicity of 24SOHC has been reported [23].
We have recently reported that high concentrations of 24SOHC
(50 μM) induce necroptosis, a form of programmed necrosis in
neuronal cells [24]. In contrast, we have also reported that low
concentrations of 24SOHC (o10 μM) suppress the production of
amyloid-β [25]. These current data show the diverse functions of
24SOHC which may be explained by concentration-dependent effects.
It has been demonstrated that certain lipid peroxidation products
exhibit not only cytotoxic effects but also cytoprotective effects as a
result of induction of adaptive responses [7]. Sub-lethal concentra-
tions of 7α(β)-hydroxycholesterol, a free radical-mediated oxidation
product of cholesterol, signiﬁcantly increase cellular glutathione
levels and enhance cell tolerance against the subsequent oxidative
stress in rat pheochromocytoma PC12 cells [26]. Other lipid perox-
idation products such as 15-deoxy-Δ12,14-prostaglandin J2 and
4-hydroxynonenal at low concentrations have also been found to
activate the NF-E2-related factor 2 pathway and increase antioxidant
capacity [27–30]. In this study, we found that stimulation of human
neuroblastoma SH-SY5Y cells with sub-lethal concentrations of
brain-speciﬁc oxysterol 24SOHC induced adaptive responses and
protected the cells against subsequent cytotoxic stress induced by
7KC. Moreover, we found that the activation of the LXR pathway
played a key role in 24SOHC-induced adaptive responses.
Material and methods
Materials
Dulbecco's modiﬁed Eagle's medium/nutrient mixture Ham's
F-12 (DMEM/F-12) was from Invitrogen. FBS was from Hyclone,
Thermo Scientiﬁc. 24SOHC was obtained from Biomol International.
7KC was from Steraloids. 9-cis retinoic acid (9cRA) and all-trans
retinoic acid (atRA) was from Wako Pure Chemical Industries.
Hoechst 33258 was from Dojindo. TO901317 was from Cayman.
27OHC was from Avanti. Oxysterols, 9cRA and atRAwere dissolved in
ethanol and stored at 20 1C. The following antibodies were from
commercial sources: ABCA1 (catalog no. NB400-105) and ABCG1
(catalog no. NB400-132), NOVUS Biologicals; Liver X Receptor β
(catalog no. K8917), Perseus Proteomics; β-actin (catalog no. A5441)
and microtubule-associated protein 2 (MAP2) (catalog no. M4403),
SIGMA. All other chemicals, of analytical grade, were from Sigma-
Aldrich or Wako.
Cell culture
SH-SY5Y human neuroblastoma cells (American Type Culture
Collection) were routinely maintained in DMEM/F-12 medium
with 10% heat-inactivated FBS and antibiotics (100 units/ml peni-
cillin, 100 mg/ml streptomycin; Invitrogen) at 37 1C under an atmo-
sphere of 95% air and 5% CO2. SH-SY5Y cells were differentiated by
treatment with 10 μM atRA for 5 days.
Immunoﬂuorescence staining
The cells grown on glass cover slips were ﬁxed with 4%
paraformaldehyde/PBS for 10 min, permeabilized with 0.5% Triton
X-100/PBS for 10 min and then blocked with 2% BSA/PBS for
30 min. The cover slips were incubated with anti-MAP2 antibody
and Alexa Fluor-conjugated secondary antibody. The nuclei were
stained with Hoechst. Confocal ﬂuorescence image was obtained
using a Zeiss LSM710 confocal microscope lasers with oil objective
lens and accompanying software (LSM Software ZEN 2009).
Determination of cell viability
To examine the toxicity of 7KC, SH-SY5Y cells were grown on
plates at a density of 4.5105 cells/ml. After the cells were attached
(16–18 h), they were treated with 24SOHC, or with 24SOHC and
9cRA, at different concentrations for 24 h. The culture medium was
thereafter replaced with fresh medium containing indicated concen-
trations of 7KC or vehicle alone. For determination of cell viability, 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay and lactate dehydrogenase (LDH) release assay were conducted
for the indicated periods, as described previously [24]. WST-8 assay
was performed using Cell Counting Kit-8 according to the manufac-
turer's instructions (Dojindo). Phosphatidylserine exposure and pro-
pidium iodide (PI) staining were analyzed as described previously
[24]. Brieﬂy, control and treated cells were labeled with annexin
V-ﬂuorescein isothiocyanate (FITC) and PI, followed by analysis
with a FACSAriaTM II Cell Sorter (BD Biosciences) with a 488-nm
argon laser.
Immunoblotting
Whole cell lysates were prepared in lysis buffer (50 mM Tris–
HCl, pH 7.4, 150 mM NaCl, 1% Nonidet P-40, 2 mM EDTA) plus
protease inhibitor cocktail (nacalai tesque). Cell debris was removed
by centrifugation. Protein samples were subjected to SDS-PAGE and
immunoblotting by using appropriate antibodies.
Knockdown of LXRβ, ABCA1 and ABCG1 in SH-SY5Y cells by small
interfering RNA
Stealth siRNA targeting human LXRβ (5′-UCAAGAAGGUGAUAC-
ACUCUGUCUC-3′), human ABCA1 (5′-CACUUCCUCCGAGUCAAGAA-
GUUAA-3′), and human ABCG1 (5′-UUCAGACCCAAAUCCCUCAA-
AUAUG-3′), as well as Stealth RNAi Negative Control (NC), were
obtained from Invitrogen. Cells grown in 6-well or 48-well plates
were transfected with 20 nM of siRNA/well by using Lipofectamine
RNAiMAX (Invitrogen) according to the manufacturer's instructions.
After 24 h incubation, the cells were subjected to 24SOHC pretreat-
ment, followed by 7KC treatments.
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RNA isolation, RT-PCR and real-time PCR
Total RNA was isolated with FastPure RNA kit (TAKARA)
according to the manufacturer's instructions. Samples were
reverse-transcribed using random hexamer and ReverTra Ace
(TOYOBO). Synthesized cDNAwas subjected to real-time PCR using
Power SYBR Green PCR Master Mix (Applied Biosystems) using the
following protocol: 10 min at 95 1C, 40 cycles of 15 s at 95 1C, and
1 min at 60 1C, and analyzed with a 7900HT Fast Real Time PCR
system (Applied Biosystems). The GAPDH gene was used for the
normalization of each reaction. The following primers were used:
ABCA1 forward, 5′-GAGCACCATCCGGCAGAA-3′; reverse, 5′-CTCCG-
CCTTCACGTGCTT-3′; ABCG1 forward, 5′-GCCTCACGCAGTTCTGCAT-
3′; reverse, 5′-GGACCGAGTCCCTCATGATG-3′; GAPDH forward,
5′-TTTGGCTACAGCAACAGGGTGGTG-3′; reverse, 5′-ATGGTACAT-
GACAAGGTGCCGCTC-3′.
Statistical analysis
Data are reported as mean7SD of at least three independent
experiments unless otherwise indicated. Statistical comparisons
were made by an analysis of variance using Tukey's test for
multiple comparisons. The difference was considered signiﬁcant
when the P value was less than 0.05.
Results
Effect of 7KC and 24SOHC on viability of neuronal cells
To evaluate the cytotoxicity of 7KC, human neuroblastoma
SH-SY5Y cells were treated with several concentrations of 7KC
for 24 h and the viability was measured by MTT assay. Since 7KC
signiﬁcantly decreased cell viability at concentrations higher than
30 μM (Fig. 1A), we chose 50 or 75 mM 7KC to induce cell death.
The 50% cell death (LD50) occurred at 37 μM 7KC. The LD50 of 7KC
in neuronal cells are similar to doses described elsewhere [14–16].
We also evaluated the cytotoxicity of 24SOHC at several concen-
trations by using WST-8 assay. The results showed that 24SOHC
signiﬁcantly decreased cell viability at concentrations above 10 mM
(Fig. 1B). Our previous paper showed that 24SOHC at concentra-
tions higher than 10 mM exhibited signiﬁcant neurotoxicity in
SH-SY5Y cells as evaluated using MTT assay and LDH assay [24].
It has been reported that SH-SY5Y contains CYP46A1 mRNA but
does not synthesize 24SOHC [31]. Therefore, we chose 1–10 μM
24SOHC as a range of sub-lethal concentrations at which 24SOHC
did not show appreciable cytotoxicity and are within the range
observed in human brain [32].
24SOHC induces adaptive responses in SH-SY5Y cells
To evaluate ability of 24SOHC to prevent cell death caused by
7KC, SH-SY5Y cells were pretreated with 0–10 μM 24SOHC for
24 h and followed by subsequent treatment with 7KC. Cell viability
was measured by MTT assay (Fig. 2A) and LDH release assay
(Fig. 2B). Pretreatment with 24SOHC at 5 μM signiﬁcantly reduced
cell death caused by 50–75 μM 7KC. To further evaluate the
protective effects of 24SOHC on 7KC-induced cell death, we
analyzed the types of cell death induced by 7KC. Using ﬂow
cytometry, apoptosis and necrosis were assessed by annexin
V-FITC staining (Fig. 2C) and PI staining (Fig. 2D), respectively.
7KC treatment increased both annexin V-FITC-positive apoptotic
cells and PI-positive necrotic cells. Pretreatment of cells with
24SOHC signiﬁcantly reduced apoptotic cell death and tended to
decrease necrotic cell death. These results showed that 24SOHC
induced adaptive responses in neuronal cells which resulted in
increased resistance to cell death caused by 7KC.
Activation of LXR pathway reduces 7KC-induced cell death
Since 24SOHC has been known to act as a ligand of LXR, we
investigated the ability of other LXR ligands to induce adaptive
responses. TO901317 is a synthetic LXR ligand. Other enzymati-
cally produced oxysterols, 25-hydroxycholesterol (25OHC) and
27-hydroxycholesterol (27OHC), are also known as endogenous
LXR ligands. As was the case with 24SOHC, pretreatment of
SH-SY5Y cells with 5 μM of TO901317, 25OHC, or 27OHC showed
protective effects against 7KC-induced cell death (Fig. 3A).
LXR forms a functional heterodimer with retinoid X receptor
(RXR) and regulates transcription of several genes involved in
the cholesterol efﬂux pathway [33]. We therefore assessed whether
co-treatment of cells with 24SOHC and RXR ligand 9-cis retinoic acid
(9cRA) enhanced the adaptive responses to prevent 7KC-induced cell
death. Co-treatment with 24SOHC and 9cRA signiﬁcantly enhanced
adaptive responses to prevent 7KC-induced cell death (Fig. 3B). The
same experiments using TO901317 and 9cRA revealed that the
adaptive responses were enhanced by co-treatment of cells with
TO901317 and 9cRA (Fig. 3C). Together, these results suggest that
activation of LXR pathway by oxysterols is involved in suppression of
7KC-induced cytotoxicity
24SOHC induces adaptive responses in differentiated SH-SY5Y cells
We conducted the experiments using differentiated SH-SY5Y
cells by treatment with atRA for 5 days. The differentiation of cells
was conﬁrmed by observation of neurite extention and immuno-
ﬂuorescence staining with a marker of differentiated neuron
MAP2 by using a ﬂuorescence microscopy (Fig. 4A). Since the
viability of the differentiated cells was decreased with concentration
dependent manner of 7KC (Fig. 4B) as observed in the undifferen-
tiated cells (Fig. 1A), we chose 60 mM 7KC to induce cell death.
Fig. 1. Cell death induced by 7KC or 24SOHC in SH-SY5Y cells. SH-SY5Y cells were
treated with variable concentrations of 7KC (A) or 24SOHC (B) for 24 h, and cell
viability was measured by MTT assay (A) and by WST-8 assay (B). Each bar
represents mean7SD (n¼3). nPo0.05, nnPo0.01, when compared with vehicle
control.
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Pretreatment with either 5 μM 24SOHC or 10 μM 9cRA, or their
co-treatment signiﬁcantly reduced cell death caused by 60 μM 7KC
(Fig. 4C), as observed in undifferentiated SH-SY5Y cells (Fig. 3B).
Knockdown of LXRβ reduces 24SOHC-induced adaptive responses
For further conﬁrmation of the involvement of LXR protein in
the adaptive responses triggered by 24SOHC, we performed siRNA
knockdown of LXRβ. The LXR family consists of two subtypes,
LXRα and LXRβ. LXRβ has a relatively higher level of expression in
the brain than LXRα [34]. Immunoblot analysis showed that LXRβ
siRNA successfully suppressed expression of LXRβ protein in both
cells with and without 24SOHC treatment (Fig. 5A). The cytopro-
tective effects of 24SOHC disappeared in LXRβ-knockdowned cells
(Fig. 5B), suggesting that LXRβ played a key role in 24SOHC-
induced adaptive responses.
Fig. 2. Pretreatment with sub-lethal 24SOHC induces adaptive responses in SH-SY5Y cells. (A) SH-SY5Y cells treated with 0–10 mM 24SOHC for 24 h then treated with 50 μM
7KC for 24 h. The cell viability was measured by MTT assay. (B) The cells were treated with 0–10 mM 24SOHC then treated with 75 μM 7KC for 24 h. The cytotoxicity was
measured by LDH assay. (C and D) The cells were treated with 5 mM 24SOHC for 24 h then treated with 60 μM 7KC for 21 h. The cell samples were then treated with annexin
V-FITC and PI and subjected to ﬂow cytometry. The percentage of cells exhibiting annexin V-FITC-positive and PI-negative apoptotic (C) and PI-positive (D) cells are shown.
Each bar represents mean7SD (n¼3). nPo0.05.
Fig. 3. Activation of LXR pathway reduces 7KC-induced cell death. (A) The cells were treated with 5 μM 24SOHC, TO901317, 25OHC or 27OHC, then treated with 75 μM 7KC
for 24 h. The cell viability was measured by MTT assay. (B and C) The cells were treated with 5 μM 24SOHC (B) or TO901317 (C) in the presence or absence of 10 μM 9cRA for
24 h. After the treatment with 75 μM 7KC, the cell viability was measured by MTT assay. Each bar represents mean7SD (n¼3). nPo0.05, nnPo0.01.
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Target genes of LXRβ responsible for 24SOHC-induced adaptive
responses
Next, we measured mRNA expression levels of LXR target genes
ABCA1, ABCG1, and ApoE by real-time PCR and measured protein
levels of ABCA1 and ABCG1 by immunoblotting. Without stimula-
tion by 24SOHC, mRNA levels as well as protein levels of ABCA1
and ABCG1 in SH-SY5Y cells are under detectable. Treatment with
either 24SOHC or TO901317 increased expression levels of both
ABCA1 and ABCG1 mRNA (Fig. 6A and B) but not ApoE mRNA
(Fig. S1). Treatment with 7KC did not change expression levels of
ABCA1 and ABCG1 mRNA. Up-regulation of ABCA1 and ABCG1
protein levels by 24SOHC or TO901317 was also conﬁrmed by
immunoblotting (Fig. 6C and D). When cells were co-treated with
9cRA and either 24SOHC or TO901317, the protein levels of ABCA1
and ABCG1 were further increased (Fig. 6E). The increase in
protein levels of ABCA1 and ABCG1 was also observed in differ-
entiated SH-SY5Y cells treated with 24SOHC in the absence or
presence of 9cRA but not in cells treated with 7KC (Fig. 6F).
ABCG1 rather than ABCA1 is responsible for the adaptive responses
induced by 24SOHC
Since expression of ABCA1 and ABCG1 was increased in cells
treated with 24SOHC or TO901317, we studied the effects of
siRNA knockdown of either ABCA1 or ABCG1 on the adaptive
responses. Without stimulation by 24SOHC, ABCA1 and ABCG1
expression were not observed in non-transfected cells (Fig. 7A
and B) as observed in Fig. 5. Treatment with 24SOHC increased
ABCA1 and ABCG1 expression in both non-transfected and NC
siRNA-transfected cells. In ABCA1 siRNA-transfected cells,
expression of ABCA1 protein was speciﬁcally suppressed without
affecting ABCG1 protein levels (Fig. 7A). In ABCG1 siRNA-
transfected cells, ABCG1 protein expression by 24SOHC treatment
was speciﬁcally suppressed without affecting ABCA1 protein
levels (Fig. 7B). These results show that siRNA for ABCA1 or ABCG1
successfully diminished 24SOHC-induced expression of ABCA1 and
ABCG1, respectively. Under these conditions, we evaluated the effects
of knockdown of either ABCA1 or ABCG1 on the induction of
Fig. 4. Pretreatment with sub-lethal 24SOHC induces adaptive responses in differentiated SH-SY5Y cells. (A–C) SH-SY5Y cells were treated with 10 mM atRA for 5 days.
(A) The cells grown on coverslips were processed for immunoﬂuorescence staining with antibody against MAP2. Blue: Hoechst, Green: MAP2. Representative confocal
images are shown. Bar, 20 μm. (B) Differentiated SH-SY5Y cells were treated with variable concentrations of 7KC for 24 h. The cell viability was measured by WST-8 assay.
(C) Differentiated SH-SY5Y cells were treated with 5 μM 24SOHC in the presence or absence of 10 μM 9cRA for 24 h. After the treatment with 60 μM 7KC, the cell viability was
measured by WST-8 assay. Each bar represents mean7SD (n¼3). nPo0.05, nnPo0.01, when compared with vehicle control. (For interpretation of the references to color in
this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 5. Knockdown of LXRβ reduces 24SOHC-induced adaptive responses in
SH-SY5Y cells. (A and B) SH-SY5Y cells were transfected with negative control
(NC) or LXRβ siRNA and incubated for 24 h then treated with 5 μM 24SOHC for 24 h.
(A) Whole cell lysates were immunoblotted with appropriate antibodies as
indicated. (B) The cells were challenged with 50 μM 7KC for 24 h. The cell viability
was measured by WST-8 assay. Each bar represents mean7SD (n¼3). nPo0.05,
nnPo0.01, when compared with vehicle control.
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adaptive responses by 24SOHC. The knockdown of ABCA1 did not
affect 24SOHC-induced adaptive responses (Fig. 7C). In contrast, in
ABCG1 siRNA-transfected cells, 24SOHC still induced adaptive
response, but the protective effect was signiﬁcantly diminished
(Fig. 7D). Knockdown of ABCG1 also reduced TO901317-induced
adaptive responses (Fig. S2). Together, these results suggest that
Fig. 6. Up-regulation of LXRβ target genes in 24SOHC-treated SH-SY5Y cells. (A–D) The cells were treated with 5 μM of 24SOHC, TO901317 or 7KC for 24 h. ABCA1 (A) and
ABCG1 (B) mRNA levels were quantiﬁed by real-time PCR, and the relative expression levels are shown. Each bar represents mean7SD (n¼3). nnPo0.01, when compared
with vehicle control. (C and D) Whole cell lysates were immunoblotted with using an antibody against ABCA1 (C) or ABCG1 (D). (E) The cells were treated with 5 μM 24SOHC
or TO901317 in the presence or absence of 10 μM 9cRA for 24 h. Whole cell lysates were immunoblotted with appropriate antibodies as indicated. (F) Differentiated SH-SY5Y
cells were treated with 5 μM 24SOHC in the presence or absence of 10 μM 9cRA, or 7KC for 24 h as Fig. 4. Whole cell lysates were immunoblotted with using an antibody
against ABCA1 or ABCG1.
Fig. 7. Knockdown of ABCG1 but not ABCA1 reduces 24SOHC-induced adaptive responses in SH-SY5Y cells. (A–D) SH-SY5Y cells were transfected with NC or ABCA1 siRNA
(A and C) or ABCG1 siRNA (B and D) and incubated for 24 h then treated with 5 μM 24SOHC for 24 h. (A and B) Whole cell lysates were immunoblotted with appropriate
antibodies as indicated. (C and D) The cells were challenged with 50 μM 7KC for 24 h. The cell viability was measured by WST-8 assay. Each bar represents mean7SD (n¼3).
nPo0.05, nnPo0.01, when compared with vehicle control. n.s.: not signiﬁcant.
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ABCG1 but not ABCA1 is involved in LXRβ-mediated adaptive
responses induced by 24SOHC.
Discussion
It has been reported that lipid peroxidation products can
induce adaptive responses against subsequent further oxidative
stress [7]. Under the induction of adaptive responses by lipid
peroxidation products, cell death caused by oxidative stress was
reduced signiﬁcantly but not completely [26–30]. In this study, we
showed that pretreatment of human neuronal cells with brain-
speciﬁc oxysterol 24SOHC at sub-lethal concentrations signiﬁ-
cantly reduced cell death induced by subsequent treatment with
7KC. It has been thought that the major function of CYP46A1 is to
maintain the cholesterol levels in the brain by converting excess
amount of cholesterol to 24SOHC [13]. Our ﬁndings suggest that
CYP46A1 and 24SOHC play important roles not only in brain
cholesterol homeostasis but also in protection of neuronal cells
against cytotoxic oxidative stress.
The present data suggest that up-regulation of LXR target genes
play a pivotal role in 24SOHC-induced adaptive responses.
We found that among the well-known LXR target genes, ABCG1
but not ABCA1 was involved in 24SOHC-induced adaptive
responses. ABCA1 and ABCG1 in the plasma membrane play
crucial roles in cholesterol efﬂux to high-density lipoprotein
(HDL) and/or apolipoprotein A-I and prevent cells from cholesterol
accumulation [35]. Terasaka et al. reported that ABCG1 but not
ABCA1 promoted efﬂux of 7KC from macrophages onto HDL and
protected macrophages against 7KC-induced cytotoxicity [36].
Another report in the literature showed that trophoblast cells
transfected with ABCG1 siRNA were more sensitive to 7KC [37].
Matsuda et al. reported that in the presence of HDL, the efﬂux of
24SOHC from differentiated SH-SY5Y cells was stimulated when
the expression of ABCA1 and ABCG1 was induced via activation of
LXR/RXR pathway, and knockdown of ABCA1 but not ABCG1
suppressed 24SOHC efﬂux [38]. All together with our present data
and these literatures suggests that LXR/RXR-regulating efﬂux of
oxysterols is dependent on cell types and oxysterol species. In our
preliminary experiments, in addition to 7KC, we have investigated
the protective effect of 24SOHC against several oxidative stress
including 7β-hydroxycholesterol, 13S-hydroperoxy-9Z,11E-octadeca-
dienoic acid, 6-hydroxydopamine, or 1-methyl-4-phenylpyridinium.
24SOHC did not show adaptive responses against other oxidative
stress (data not shown). Such varied effects of 24SOHC on cytotoxi-
city of different oxidative stress species may be explained by the
difference in their efﬂux mechanisms and/or metabolic pathways.
Although ABCG1 had been considered to localize in plasma
membranes and contribute to cholesterol efﬂux to HDL, it has
been indicated that ABCG1 localizes to endosome and facilitates
the redistribution of intracellular sterol from the endoplasmic
reticulum to plasma membranes [39]. It has also been reported
that incorporation of 7KC to lipid raft domains of plasma mem-
branes triggers apoptotic signaling, and α-tocopherol, a lipophilic
antioxidant, reduced cytotoxicity of 7KC by inhibiting distribution
of 7KC into the lipid raft domains [40,41]. It has recently been
reported that ABCG1 mediates the generation of cell surface
associated extracellular cholesterol microdomain which serves
for reverse cholesterol transport by HDL [42]. Therefore, there is
a possibility that 24SOHC induces adaptive responses via ABCG1-
mediated intracellular and extracellular redistribution of 7KC.
It might be noteworthy that while siRNA for LXRβ completely
suppressed 24SOHC-induced adaptive responses, ABCG1 siRNA
signiﬁcantly but not completely abolished them. Although the
efﬁcacy of siRNA for ABCG1 was not good enough to inhibit its
expression, it is likely that other LXR target genes may also
contribute to 24SOHC-induced adaptive responses.
Oxidative damage has been implicated in neurodegenerative
diseases [7,8]. Oxidative insult in the brain leads to oxidation of lipid
and may contribute to the pathogenesis of neurodegenerative dis-
eases. As had previously been reported in the literatures [14–16], we
showed that 7KC induces apoptosis in neuronal cells. The current
data therefore suggests that in addition to the role of 24SOHC for
cholesterol homeostasis in the brain, its cytoprotective function
should also be important for keeping the brain in good health. In
line with our ﬁndings, synthetic LXR ligands could become candi-
dates for therapeutic drug design against neurodegenerative diseases
such as AD and multiple sclerosis [43].
Conclusions
Taken together, these results demonstrate that brain speciﬁc-
generated oxysterol, 24SOHC protects neuronal cells from
7KC-induced cell death via induction of adaptive responses. We
attribute the molecular mechanisms of 24SOHC-induced adaptive
responses against 7KC cytotoxicity to up-regulation of LXR-
target genes.
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